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ABSTRACT
MOD
i (http://modi.uos.ac.kr/modi/) is a powerful and
convenient web service that facilitates the inter-
pretation of tandem mass spectra for identifying
post-translational modifications (PTMs) in a peptide.
It is powerful in that it can interpret a tandem mass
spectrum even when hundreds of modification types
are considered and the number of potential PTMs in a
peptide is large, in contrast to most of the methods
currentlyavailableforspectrainterpretationthatlimit
thenumberofPTMsitesandtypesbeingusedforPTM
analysis. For example, using MOD
i, one can consider
for analysis both the entire PTM list published on
the unimod webpage (http://www.unimod.org) and
user-defined PTMs simultaneously, and one can
also identify multiple PTM sites in a spectrum. MOD
i
is convenient in that it can take various input file for-
matssuchas.mzXML,.dta,.pkland.mgffiles,anditis
equipped with a graphical tool called MassPective
developed to display MOD
i’s output in a user-friendly
manner and helps users understand MOD
i’s output
quickly. In addition, one can perform manual
de novo sequencing using MassPective.
INTRODUCTION
Identiﬁcation of post-translational modiﬁcations (PTMs) is
important to understand cellular functions of proteins (1).
Sensitive methodologies based on conventional biochemical
methods are lacking for the identiﬁcation of PTMs in vivo, but
recent advances in proteomic technology including mass
spectrometry provide an approach to identify PTMs (2–5).
Sequencing by tandem mass spectrometry (MS/MS) which
has aided protein identiﬁcation offers a tremendous potential
for detecting PTMs (1).
Three approaches have been used to automatically interpret
tandem mass spectra for peptide sequencing (6), namely, data-
base searching (7–9), de novo peptide sequencing (10–12) and
sequence tag approach (13,14), and there have also been
efforts to combine these methods (15,16). Interpretation of
experimental spectra is harder if a peptide sequence contains
PTMs. One might consider extending one of these approaches
in a straightforward manner to sequence a peptide with any
number, any kind and any combination of PTMs, i.e. devel-
opingavirtualpeptide database byincorporatingpeptideswith
all possible combinations of PTMs, or extend the set of amino
acids by introducing new virtual amino acids such that the
mass of each virtual amino acid corresponds to the mass of a
post-transitionally modiﬁed amino acid. However, such exten-
sions yield an exponential time algorithm or a polynomial
time algorithm, the degree of which is very high. Thus these
algorithms are not appropriate to interpret tandem mass spec-
tra with multiple PTMs in a reasonable amount of time.
Recently there have been efforts to formally deﬁne this prob-
lem and suggest a way to reduce the time requirement of
PTM identiﬁcation (17,18).
We have developed a convenient method called MOD
i for
rapidly interpreting tandem mass spectra of peptides with mul-
tiple PTMs. This method adopts a hybrid approach that com-
bines de novo sequencing with database searching. It performs
well even when a large number and types (>100 modiﬁcation
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doi:10.1093/nar/gkl245types) of potential PTMs are considered. In addition, we
developed a graphical tool called MassPective that shows
MOD
i’soutputinauser-friendlymanner.MassPectiveenables
a user not only to quickly view and understand MOD
i’s output,
but also to perform additional manual de novo sequencing so
that a MOD
i’s interpretation can be manually inspected.
By incorporating MOD
i and MassPective with web-based
interface, we have produced MOD
i web service. MOD
i web
will provide the biological community a fast and convenient
vehicle for identifying PTMs from tandem mass spectra.
METHODS
MOD
i consists of ﬁve stages: peak selection, tag discovery,
database search, tag chain generation and PTM identiﬁcation.
It assumes that the number of candidate proteins has already
been reduced to 20 or less by protein identiﬁcation, before the
spectra set is analyzed for PTM identiﬁcation.
(i) Peak selection: We select peaks with relatively high
intensities (both globally and locally). The number of
peaks selected is proportional to a parent ion mass.
(ii) Tag discovery: We perform partial de novo sequencing on
the selected peaks to identify all the tags (partial amino
acidsequences thatdonot containPTMs) oflengthupto3.
(iii) Database search: Using the tags identified, we search the
peptide database for candidate peptides that contain any
of the identified tags (called forward tags) or the reverse
sequences of the identified tags (called reverse tags) of
length at least 3. It should be noted that the peptide
database we use does not contain any PTM information.
Thus the scalability requirement is satisfied.
(iv) Tag chain generation: For each candidate peptide, we
build a tag chain. A tag chain for a candidate peptide
consists of non-overlapping forward or reverse tags of
length at least 2, occurring in the candidate peptide and
in-between gaps, where each gap is a maximal consecu-
tive amino acid subsequence of the candidate peptide that
is not covered by any tags. The difference between the
mass of a gap and the size of its aligned segment of the
spectrum is called mass offset for the gap. (Figure 1)
(v) PTM identification: For each gap of a tag chain, we find a
set of PTMs that best interprets the gap. We first enu-
merate candidate sets of PTMs that correspond to the
mass offset of each gap, and then select the best candidate
set by comparing the partial theoretical spectra generated
by each candidate set with the partial experimental spec-
trum of the gap.
INPUT, OUTPUT AND PARAMETERS
Input
MOD
i requires users to input spectra, protein database and
PTM database.
(i) Spectra. MOD
i can take several different formats of spec-
tra: ISB mzXML format (*.xml), Thermo Finnigan
dta format (possibly compressed to a *.zip format),
Figure 1. Atagchain‘__GG_glg_gga__’foraspectrumfromhistone.Asequenceofcapitallettersrepresentsaforwardtag,asequenceofsmalllettersareversetag
and each underline a gap. This tag chain consists of one forward tag ‘GG’, two reverse tags ‘glg’ and ‘gga’ and four gaps in between. A mass offset for a gap can be
calculatedbysubtractingthemassofagapfromthesizeofitsalignedsegmentofthespectrum.Forexample,themassoffsetoftheleftmostgapcanbecalculatedas
41.947Da,basedonthe sizeof alignedsegmentof227.063(228.0631) andthe massofthe sequence‘GK’corresponding tothe gapof185.116(Glycine:57.021,
Lysine: 128.095).
Nucleic Acids Research, 2006, Vol. 34, Web Server issue W259Micromass pkl format (*.pkl) and Mascot mgf format
(*.mgf). For reliable interpretation of PTMs, we recom-
mend users to input spectra with mass error tolerance
<1 Da.
(ii) Protein database. Protein database should be in fasta
format (*.fasta) and contain 20 or less protein sequences
because a large protein database may produce bulky false
positive results.
(iii) PTM database. MOD
i can consider the entire unimod
PTMs published in http://www.unimod.org. In addi-
tion, users can configure their tailored PTM list
composed of selected unimod PTMs and user-defined
PTMs. It is possible to save and load user-selected
PTM lists.
Parameters
Users can adjust MOD
i parameters appropriately according to
one’s experimental conditions. The parameters include max-
imum number of missed cleavages, mass tolerance, precursor
mass tolerance and enzymes used. In addition, users can ﬁne-
tune MOD
i by ﬁtting advanced parameters such as offset
minimum/maximum value per gap, tag chain discard rate,
minimum normalized intensity to consider, peak selection
window size and minimum/maximum peaks in a window.
Users can save parameters on a local host to re-use them
for later analysis. A more detailed description of each para-




i outputs a unidta ﬁle (*.unidta) and a unidrawing ﬁle
(*.unidrawing). To guarantee random access, each ﬁle has a
tailing offset list which indicates ﬁle offsets of input spectra.
The unidta ﬁle is a set of input spectra and the unidrawing ﬁle
is an XML formatted ﬁle which contains interpretations of
input spectra.
MassPective
MassPective has been developed to help users understand the
interpretation from unidta and unidrawing ﬁles. MassPective
is a graphical tool that displays MOD
i’s output in a user-
friendly manner and helps users understand MOD
i’s output
quickly. It shows each spectrum with ion-type annotation,
candidate peptides for the spectrum, tag-chains for the can-
didate peptides and possible PTM interpretations for the tag-
chains using graphical user interface. In addition, it enables
users to perform additional manual de novo sequencing so that
aM O D
i’s partial interpretation can be manually annotated
with additional sequencing information.
Given a spectrum, MassPective displays MOD
i’s output in
three tiled windows (candidate peptide list, detailed informa-
tion, and spectrum windows) and a pop-up gap list window
(Figure 2). Candidate peptide list window shows candidate
peptides for the current spectrum and tag-chains of each can-
didate peptide. By selecting a candidate peptide or a tag chain,
a user can see useful information such as score, offset list or
gap list in the detailed information window. If a user clicks a
tag chain, a pop-up window showing gap list appears. Gap list
window shows combinations of PTMs that may occur in each
gap and their scores and a user can select an interpretation of
each gap so that the corresponding annotation in the spectrum
window can be displayed. Spectrum window displays the
selected spectrum together with various annotations a user
selects. By clicking buttons in the toolbar, a
user can see spectral alignment of y ion tags, b ion tags,
theoretical y-ion peaks and theoretical b-ion peaks
respectively.
Figure 2. MassPective screen shot. This is the interpretation of a spectrum corresponding to the peptide ‘GKGGKGLGKGGAKR’ of histone. It shows spectral
alignments of y ion tags, theoretical y-ion peaks, and their ion annotation in red and those of their b counterparts in blue.
W260 Nucleic Acids Research, 2006, Vol. 34, Web Server issueAnother function of MassPective is to report protein
summary in CSV (Comma-Seperated Values) ﬁle format
(Figure 3) or save spectral image in *.bmp or *.jpeg format
and print out the currently displayed spectrum.
MassPective also supports manual de novo sequencing
with PTMs by identifying every amino acid (possibly with
a PTM) of which mass corresponds to the mass




i web server has been tested by four groups: a group that
uses a nano-LC/MS–MS system consisting of an Ultimate
HPLC system (LC Packings) for nano-LC and a Q-TOF
Ultima Global mass spectrometer (Micromass) equipped
with a nano-ESI source, a group that uses a Finnigan LTQ
equipped with ‘in-house’ nano-ESI source, a group that uses
Finnigan LCQ equipped with ‘in-house’ nano-LC system and
a group that uses Applied Biosystems 4700 Proteomics
Analyzer MALDI-TOF/TOF equipped with Agilent 1100
series capillary HPLC system.
Figure 5 shows how MOD
i interprets a spectrum with mul-
tiple modiﬁcations successfully. MOD
i interprets the spectrum
as a peptide ‘GKGGKGLGKGGAKR’ with four acetylation
sites at every Lysine in the peptide. As shown in Figure 5,
MOD
i ﬁrst ﬁnds a tag chain __GG _glg_gga__, computes the
mass offsets of the gaps, which are 41.95, 41.92, 41.94 and
Figure 4. Manual sequencing by MassPective. If a user designates an area in the spectrum, a window pops up showing all possiblecombinations of one amino acid
mass possibly with one PTM whose mass agrees with the difference of two peaks in the area with higher intensity than the intensity value of the designated line.
Figure 3. AproteinsummaryreportgeneratedbyMassPective.ItisasummaryoftheoutputofMOD
iforeachidentifiedprotein,containingproteininformationand
sequence coverage for proteins which correspond to input spectra. Also, for each interpreted spectrum, it gives a submitted mass, matched peptide sites in protein
sequence, match score, a spectrum identifier and identified PTMs.
Nucleic Acids Research, 2006, Vol. 34, Web Server issue W26141.93 Da, respectively, estimates four acetylation sites from
the mass offsets and evaluates the estimation by a simple
scoring scheme.
MOD
i can ﬁnd multiple PTMs in a single gap. In Figure 6,
MOD
i identiﬁes a deamidation on ‘N’ and a di-methylation on
‘K’ in a gap ‘NGK’. In general, considering various combina-
tions of possible modiﬁcations requires prohibitively huge
computational time as the numbers of possible modiﬁcation
sites and types increase. This example demonstrates how
MOD
i successfully manages the time complexity of modiﬁca-
tion analysis problem so that it can spend time on identifying
multiple closely located PTMs in a peptide. This is possible
because MOD
i has already identiﬁed regions in a peptide that
do not contain modiﬁed residues and are anchored on those
sites before starting modiﬁcation analysis for each gap. Thus,
it narrowed down the search space for multiple PTMs to each
gap region of a peptide, which is generally a lot shorter than
the entire peptide length.
DISCUSSION
Identifying multiple PTMs in a single gap mandates trying all
possible combinations of feasible PTMs. This implies that as
the number and the type of PTMs being considered grow, the
number of combinations grows exponentially. This is the
reason why most of the previous methods limit the number
of PTM sites and PTM types being considered. However, we
manage the computational complexity of PTM identiﬁcation
Figure 6. Shows that MOD




an acetylation and the estimation is evaluated by a scoring scheme.
W262 Nucleic Acids Research, 2006, Vol. 34, Web Server issueinnovatively and therefore MOD
i can interpret a tandem mass
spectrum when hundreds of modiﬁcation types are considered
and the number of potential PTMs in a peptide is large. MOD
i
is different from existing methods based on sequence tags in
that it aligns multiple sequence tags to a candidate peptide and
isolates regions that might include post-translationally
modiﬁed amino acids, while most of the previous methods
align a single tag to a candidate peptide and try to identify
modiﬁcations over the entire peptide. By ﬁrst ﬁxing unmodi-
ﬁed regions in a peptide and then interpreting potentially
modiﬁed amino acids in relatively small regions in between
these unmodiﬁed tags, MOD
i can greatly reduce the search space
for PTMs. In our experiments, MOD
i demonstrates its power by
identifying uncommon modiﬁcations and artefacts such as
di-methylation, acrylamide adduct (propionamide), cysteine
oxidation to cysteic acid and tryptophan oxidation to formylky-
nurenin. Such results are in accordance with the recent publication
by Pevzner group where a variety of PTMs are reported (18).
Owing to the efﬁciency gain obtained by our method, MOD
i
runs in a reasonable amount of time. We tested MOD
i on a
web server of Intel Xeon 3.06 GHz dual processor with 2 GB
memory, running Windows Server 2003. For a dataset of
5684 spectra, with 211 different PTM types downloaded
from http://www.unimod.org and nine protein sequences,
obtained from Mascot’s protein ID results, in the Protein
DB, it took 360 s. When the same dataset was run with a
database of 20 proteins (additional 11 random proteins from
IPI human database), it took 1070 s.
The current version of MOD
i assumes that the number of
candidateproteinsislimitedto20orless,andfocusesonﬁnding
PTMs in tandem mass spectra. Candidate proteins can be easily
identiﬁed using tandem mass spectra that do not contain PTMs
using any of existing methods such as SEQUEST, Mascot or
X!Tandem(7,8,19).Inordertoconductproteinidentiﬁcationon
the same web server, instead of using separate software tools,
we are planning to generalize the current version of MOD
i so
that it also includes the protein identiﬁcation step.
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